
Invisible Shield QuickFire Challenge
Up to $200,000 in funding
获奖者
Univ. of Michigan/Taza Aya Taza Aya专门从事用于在各种行业和应用中对通风空气进行消毒或除臭的非热等离子体。 |
Overview
Respiratory pathogens are everywhere. While they cannot be seen, they can massively impact individuals and communities. How can we better protect ourselves against these invisible threats? The solution may be an “invisible shield.” The future of pathogen protection can go beyond traditional respiratory devices, to integrate seamlessly into our daily lives, becoming an “invisible shield” against disease.
作为后续的Reimagining Respiratory Protection QuickFire Challenge,生物医学高级研究与发展局(Barda),美国卫生与公共服务部准备和响应助理部长办公室的组成部分,以及Johnson&Johnson Innovation -JLABS - JLABS,与JANSEN RENSPRIENG,LLC合作,很自豪地介绍Invisible Shield QuickFire Challenge。Innovators are invited to submit ideas for potential solutions that repel and protect against airborne viruses while integrating seamlessly into everyday life.
The innovator(s) with the best idea will be awarded up to $200,000 in funding from BARDA, access to the Johnson & Johnson Innovation – JLABS ecosystem, and support in developing their ideas from BARDA for one year, to support health security products and technologies in biotechnology, life science research, and medical innovations as they navigate research, development, and regulatory pathways.
奖励和利益
- Up to two innovators will be awarded up to $200,000 in funding from BARDA
- 约翰从BARDA和专家指导on & Johnson Family of Companies for one year
- Access to the Johnson & Johnson Innovation - JLABS ecosystem
What we're looking for
这项挑战寻求潜在的解决方案,该解决方案有目的用于为个人和社区提供保护免受呼吸道病原体(包括空气传播病毒)的保护。在这项挑战中,不考虑仅提供针对工业或环境因素(尤其是空气污染)保护的技术。
Proposals containing or describing a path forward to meet any of the following criteria are preferred but not required. Please keep in mind that no idea is too big or too early for consideration.在评估期间,还将考虑清楚地描述实现这些目标的概念或前进的概念或途径的应用。理想的潜在解决方案将具有以下特征:
- 适合所有年龄和人口
- 有效预防感染
- Unobtrusive
- Easily integrates into daily life
- Simple, requires no special instructions
- Safe, non-toxic to humans and animal life
- Inexpensive or low cost per use
Application process
Solutions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria:
- 新奇
- 潜在影响
- Feasibility/Practicality
- Quality of Team and Resources
- Plan for use of funds
- Clarity of plan: Milestones & defined go/no go decisions
为什么这个挑战对我们很重要
At Johnson & Johnson Innovation, we believe a good idea can come from anywhere, and it’s our goal to find new and innovative technologies that aim to provide solutions to patients from across the world. Working together, we can spark the next great idea that can potentially change the trajectory of health.
FAQs
What if I’m having trouble accessing the portal/website?
Make sure your browser is up to date and accepting cookies. You can contact customer service at[email protected]如果您也遇到技术困难。
我可以作为我的应用程序的一部分提交支持文档(例如视频)吗?
You will have the opportunity and are encouraged to upload supporting materials such as slide decks, research papers, and videos as part of your application. You may submit a video along with your typed responses. Maximum length is 2 minutes.
如果我提交的一些信息是机密的,可以吗?
Do not submit confidential information. Only non-confidential information should be submitted and anything you submit will be treated as non-confidential.
What happens with IP (Intellectual Property)?
由于这是一个没有连接的字符串的安排,因此JLABS不会获得任何IP。任何IP创建和/或保护仍然是发明者的唯一责任。
Is a patent required to apply?
不,不需要专利申请。但是,您不应提交任何要保密的信息,也不应对发明的未来专利性产生负面影响。
What kind of science / technology is appropriate for the Challenges?
We encourage all to apply. Find out more about what areas we desire to explore here:https://www.jnjinnovation.com/partnering
谁有资格申请?
每个挑战都有自己的条款和条件,可以在填写申请书之前找到。
What criteria will be used to evaluate an application?
申请将由独立审阅者和法官的小组评估,以满足以下标准的能力:
- Uniqueness of the idea
- Potential impact on human health
- Identification of key resources and plan to further idea
如果我对挑战或申请过程有疑问,我可以联系谁?
Please contact[email protected]with any questions.
时间线
关于BARDA
建立了美国卫生与公共服务部(HHS)助理秘书的一部分的生物医学高级研究与发展局(Barda)的一部分,以帮助确保我们的国家免受化学,生物学,放射学和核(CBRN)威胁,以及来自大流行性流感(PI)和新兴的传染病(EID)。Barda支持医疗对策的过渡,例如疫苗,药物,诊断和设备从研究到高级开发,再到FDA的批准,并纳入了战略性的国家库存。Barda的支持包括资金,技术援助和核心服务。迄今为止,巴尔达(Barda)已为45种针对CBRN,PI和EID威胁的独特产品提供了50项FDA批准。
关于the Janssen Pharmaceutical Companies of Johnson & Johnson
At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working tocreate a world without disease. Transforming lives by finding new and better ways toprevent, intercept, treat and cure disease inspires us. We bring together the best minds并追求最有前途的科学。
我们是詹森。我们与世界合作,以实现其中的每个人的健康。学习more atwww.janssen.com。Follow us at@JanssenGlobal。
关于Johnson & Johnson Innovation
Johnson&Johnson Innovation,LLC致力于加快全球创新的所有阶段,并在企业家和Johnson&Johnson的全球医疗保健业务之间建立合作。Johnson&Johnson Innovation为科学家,企业家和新兴公司提供一站式访问科学和技术专家,他们可以促进约翰逊和约翰逊的药品,医疗设备和消费者公司的合作。在Johnson&Johnson的创新伞下,我们通过区域创新中心与创新者联系;Johnson&Johnson Innovation - Jlabs;Johnson&Johnson Innovation - JJDC,Inc。;我们的业务开发团队旨在创建定制的交易和新颖的合作,以加快创新的发展,以解决患者未满足的需求。JLABS为帮助生命科学创业公司蓬勃发展所需的实验室,专业知识,教育,工具和资源提供,所有这些创业公司都没有附带。已建立了德克萨斯医疗中心(CDI @ TMC)的Johnson&Johnson创新创新中心,以加速医疗设备的开发。有关Johnson&Johnson Innovation的更多信息,请访问:www.jnjinnovation.com。
关于Johnson & Johnson Innovation - JLABS
Johnson & Johnson Innovation-JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS, we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS also produces campaigns to seek out the best science called QuickFire Challenges. For more information, visitwww.www.2574design.com或跟随@JLABS。